Exelixis reported $323K in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Agios Pharmaceuticals AGIO:US USD 71K 0
Akebia Therapeutics AKBA:US USD 2K 0
AstraZeneca AZN:LN USD 387M 0
Bayer BAYN:GR EUR 2.52B 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Cytokinetics CYTK:US USD 93K 8K
Eisai 4523:JP JPY 44.99B 0
Esperion Therapeutics ESPR:US USD 72K 7K
Exelixis EXEL:US USD 323K 1000
Genmab GEN:DC DKK 66M 0
Glaxosmithkline GSK:US GBP 1.35B 0
Immunogen IMGN:US USD 2.21M 2K
IONIS PHARMACEUT IONS:US USD 142K 0
Macrogenics MGNX:US USD 615K 0
Mirati Therapeutics MRTX:US USD 58K 2K
Moderna Inc MRNA:US USD 38.7K 500
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NOVN:VX USD 890M 0
Seattle Genetics SGEN:US USD 185K 1000
Takeda 4502:JP JPY 1.68T 4M
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Xencor XNCR:US USD 598K 0
YTE INCY:US USD 222K 0